What is it about?
In vivo validation of a small molecule lead compound targeting tau aggregation
Featured Image
Why is it important?
Promising approach for inhibiting the progression of Alzheimer's disease
Perspectives
This paper shows that a small molecule approach targeting tau self-association can be used to develop drugs targeting all forms of tau aggregates
Eliot Davidowitz
Oligomerix Inc
Read the Original
This page is a summary of: In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice, Journal of Alzheimer s Disease, January 2020, IOS Press,
DOI: 10.3233/jad-190465.
You can read the full text:
Resources
Contributors
The following have contributed to this page
